SELLAS Life Sciences Group, Inc. (SLS)

4.28 -0.04 (-0.93%) USD  |  NASDAQ  |  Jan 21, 10:08
More

SELLAS Life Sciences Group Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade